Skip to content
OpenCapital
Get started

Dorman Products DORM Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value at other companies

Repligen logo
RepligenRGEN
$155.80—
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$54.10+21.0%
Repligen logo
RepligenRGEN
$129.34—
PNC Financial Services logo
PNC Financial ServicesPNC
$190.93+34.7%
BancFirst Corporation logo
BancFirst CorporationBANF
$88.49—
BancFirst Corporation logo
BancFirst CorporationBANF
$110.00-3.0%

Other financials

Income statement

See full
Revenue$528.8M+4.2%
Gross profit$190.2M-8.5%
Operating income$58.8M-26.6%
Net income$43.6M-24.3%
EPS (diluted)$1.43-23.5%

Balance sheet

See full
Cash & equivalents$43.1M-29.0%
Total debt$533.2M-5.3%
Total equity$1.5B+9.7%
Total assets$2.4B+0.3%

Cash flow

See full
Operating cash flow$43.8M-14.6%
CapEx$8.4M-23.1%
Free cash flow$35.3M-12.3%

Valuation

See full
Market cap$3.76B-14.6%
Enterprise value$4.25B-13.1%
P/E19.7×-0.7×
P/S1.8×-0.4×

Profitability

See full
Gross margin40.9%+0.3pp
Operating margin12.9%-2.6pp
Net margin8.8%-1.6pp
FCF margin3.3%-6.0pp

Returns & leverage

See full
Return on equity13.6%-3.5pp
Debt / equity0.4×-0.1×
Current ratio3.3×+0.7×

Where this comes from

Reported directly by Dorman Products in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.

The official record: Dorman Products’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dorman Products's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dorman Products's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value?
Dorman Products (DORM) reported share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value of $121.19 in Q1 2026.
How has Dorman Products's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value changed year-over-year?
Dorman Products's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value increased by 5.6% year-over-year, from $114.75 to $121.19.
What is the long-term trend for Dorman Products's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value?
Over 3 years (2022 to 2025), Dorman Products's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value has grown at a 8.5% compound annual growth rate (CAGR), from $92.07 to $117.7.